Xiaojun Tang - Search Results

Year	Number of Results
2000	1
2002	2
2003	1
2004	1
2005	3
2006	4
2007	7
2008	4
2009	6
2010	8
2011	17
2012	19
2013	18
2014	29
2015	20
2016	23
2017	24
2018	21
2019	27
2020	49
2021	39
2022	51
2023	54
2024	24

1

Immune cell membrane-based biomimetic nanomedicine for treating cancer metastasis.

Zhu L, Yu X, Cao T, Deng H, Tang X, Lin Q, Zhou Q. Zhu L, et al. Among authors: tang x. Acta Pharm Sin B. 2023 Jun;13(6):2464-2482. doi: 10.1016/j.apsb.2023.03.004. Epub 2023 Mar 8. Acta Pharm Sin B. 2023. PMID: 37425034 Free PMC article. Review.

2

Clinical and immunological assessment of asymptomatic SARS-CoV-2 infections.

Long QX, Tang XJ, Shi QL, Li Q, Deng HJ, Yuan J, Hu JL, Xu W, Zhang Y, Lv FJ, Su K, Zhang F, Gong J, Wu B, Liu XM, Li JJ, Qiu JF, Chen J, Huang AL. Long QX, et al. Nat Med. 2020 Aug;26(8):1200-1204. doi: 10.1038/s41591-020-0965-6. Epub 2020 Jun 18. Nat Med. 2020. PMID: 32555424

3

A novel mechanism for macrophage pyroptosis in rheumatoid arthritis induced by Pol β deficiency.

Gu L, Sun Y, Wu T, Chen G, Tang X, Zhao L, He L, Hu Z, Sun L, Pan F, Yin Z, Guo Z. Gu L, et al. Among authors: tang x. Cell Death Dis. 2022 Jul 6;13(7):583. doi: 10.1038/s41419-022-05047-6. Cell Death Dis. 2022. PMID: 35794098 Free PMC article.

4

Risk factors for cardiovascular adverse events from immune checkpoint inhibitors.

Luo L, Liu Y, Lu J, Zhang Y, Fan G, Tang X, Guo W. Luo L, et al. Among authors: tang x. Front Oncol. 2023 Apr 28;13:1104888. doi: 10.3389/fonc.2023.1104888. eCollection 2023. Front Oncol. 2023. PMID: 37188194 Free PMC article. Review.

5

SHIP1 is required for the formation of neutrophil extracellular traps in rheumatoid arthritis.

Cheng Z, Xia NL, Chen Z, Li M, Tang Z, Wu H, Yan X, Wang Y, Wang Y, Tang X, Zhang H, Sun L. Cheng Z, et al. Among authors: tang x. Int Immunopharmacol. 2023 Feb;115:109625. doi: 10.1016/j.intimp.2022.109625. Epub 2022 Dec 29. Int Immunopharmacol. 2023. PMID: 36586275

6

ZCCHC4 Promotes Osteosarcoma Progression by Upregulating ITGB1.

Luo L, Tang X, Liu L, Tang G, Chen L, Chang G, Xiao Z. Luo L, et al. Among authors: tang x. Crit Rev Eukaryot Gene Expr. 2023;33(8):31-39. doi: 10.1615/CritRevEukaryotGeneExpr.2023047798. Crit Rev Eukaryot Gene Expr. 2023. PMID: 37606162

7

The influence of gender and laterality on the incidence of hemifacial microsomia.

Xu S, Zhang Z, Tang X, Yin L, Liu W, Shi L. Xu S, et al. Among authors: tang x. J Craniofac Surg. 2015 Mar;26(2):384-7. doi: 10.1097/SCS.0000000000001336. J Craniofac Surg. 2015. PMID: 25723655 Review.

8

The DNA replication regulator MCM6: An emerging cancer biomarker and target.

Zeng T, Guan Y, Li YK, Wu Q, Tang XJ, Zeng X, Ling H, Zou J. Zeng T, et al. Clin Chim Acta. 2021 Jun;517:92-98. doi: 10.1016/j.cca.2021.02.005. Epub 2021 Feb 18. Clin Chim Acta. 2021. PMID: 33609557 Review.

9

Adverse reactions to cosmetic implants after COVID-19 vaccination: A literature review.

Cheng WJ, Cai ZX, Tang XJ. Cheng WJ, et al. J Cosmet Dermatol. 2023 Dec;22(12):3199-3212. doi: 10.1111/jocd.15828. Epub 2023 Aug 17. J Cosmet Dermatol. 2023. PMID: 37592436 Review.

10

Caregiver-Delivered Stroke Rehabilitation in Rural China.

Zhou B, Zhang J, Zhao Y, Li X, Anderson CS, Xie B, Wang N, Zhang Y, Tang X, Prvu Bettger J, Chen S, Gu W, Luo R, Zhao Q, Li X, Sun Z, Lindley RI, Lamb SE, Wu Y, Shi J, Yan LL. Zhou B, et al. Among authors: tang x. Stroke. 2019 Jul;50(7):1825-1830. doi: 10.1161/STROKEAHA.118.021558. Epub 2019 Jun 10. Stroke. 2019. PMID: 31177978 Free article. Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Results by year

Text availability

Article attribute

Article type

Publication date

396 results

Results by year

Search Page

Filters

My NCBI Filters

Results by year

Text availability

Article attribute

Article type

Publication date

Search Results

396 results

Results by year